Signaling mechanisms that mediate invasion in prostate cancer cells

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 283-288

  Bonaccorsi, L ^a   Marchiani, S ^a   Muratori, M ^a   Carloni, V ^a   Forti, G ^a   Baldi, E ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Epidermal growth factor; Invasion; Phosphatidylinositol 3 kinase; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MATRIGEL; METRIBOLONE; PHOSPHATIDYLINOSITOL 3 KINASE;

AUTOPHOSPHORYLATION; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; PHENOTYPE; PROSTATE CANCER; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

EID: 14944371181     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1322.032     Document Type: Conference Paper

References (20)

1. GRÖNBERG, H. 2003. Prostate cancer epidemiology. Lancet 361: 859-864.
2. AMANATULLAH, D.F., A.T. REUTENS, B.T. ZAFONTE, et al. 2000. Cell-cycle dysregulation and the molecular mechanisms of prostate cancer. Front. Biosci. 5: 372-390.
3. BONACCORSI, L., V. CARLONI, M. MURATORI, et al. 2000. Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. Endocrinology 141: 3172-3182.
4. CINAR, B., K.S. KOENEMAN, M. EDLUND, et al. 2001. Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line. Cancer Res. 61: 7310-7317.
5. BALDI, E., L. BONACCORSI & G. FORTI. 2003. Androgen receptor: good guy or bad guy in prostate cancer invasion? Endocrinology 144: 1653-1655.
6. WELLS, A., J. KASSIS, J. SOLAVA, et al. 2002. Growth factor-induced cell motility in tumor invasion. Acta Oncol. 41: 124-130.
7. RUSSELL, P.J., S. BENNETT & P. STRICKER. 1998. Growth factor involvement in progression of prostate cancer. Clin. Chem. 44: 705-723.
8. DI LORENZO, G., G. TORTORA & F.P. D'ARMIENTO. 2002. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin. Cancer Res. 8: 3438-3444.
9. ALBANELL, J., F. ROJO, S. AVERBUCH, et al. 2002. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J. Clin. Oncol. 20: 110-124.
10. BLACKLEDGE, G., S. AVERBUCH, A. KAY & J. BARTON. 2000. Anti-EGF receptor therapy. Prostate Cancer Prostatic Dis. 3: 296-302.
11. BONACCORSI, L., M. MURATORI, V. CARLONI, et al. 2004. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells. Steroids 69: 549-552.
12. BONACCORSI, L., M. MURATORI, V. CARLONI, et al. 2003. Androgen receptor and prostate cancer invasion. Int. J. Androl. 26: 21-25.
13. SHAW, L.M. 2001. Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol. Cell. Biol. 21: 5082-5093.
14. CANTLEY, L.C. 2002. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
15. LIN, H.K., Y.C. HU, L. YANG, et al. 2003. Suppression vs. induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers. J. Biol. Chem. 278: 50902-50907.
16. MURILLO, H., H. HUANG, L.J. SCHMIDT, et al. 2001. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 142: 4795-4805.
17. SIROTNAK, F.M., Y. SHE, F. LEE, et al. 2002. Studies with CWR22 xenografts in nude mice suggest that gefitinib may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer. Clin. Cancer Res. 8: 3870-3876.
18. VICENTINI, C., C. FESTUCCIA, G.L. GRAVINA, et al. 2003. Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures. J. Cancer Res. Clin. Oncol. 129: 165-174.
19. HOFER, D.R., E.R. SHERWOOD, W.D. BROMBERG, et al. 1991. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res. 51: 2780-2785.
20. PENG, D., Z. FAN, Y. LU, et al. 1996. Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Res. 56: 3666-3669.